Head to Head Survey: Strata Skin Sciences (NASDAQ:SSKN) versus Zhongchao (NASDAQ:ZCMD)

Strata Skin Sciences (NASDAQ:SSKN) and Zhongchao (NASDAQ:ZCMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Valuation & Earnings

This table compares Strata Skin Sciences and Zhongchao”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98 million	0.02	-$10.09 million	($1.41)	-0.09
Zhongchao	$11.38 million	0.01	-$6.31 million	N/A	N/A

Zhongchao has lower revenue, but higher earnings than Strata Skin Sciences.

Profitability

This table compares Strata Skin Sciences and Zhongchao’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
Zhongchao	N/A	N/A	N/A

Insider & Institutional Ownership

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 1.7% of Zhongchao shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by company insiders. Comparatively, 28.6% of Zhongchao shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Volatility and Risk

Strata Skin Sciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, Zhongchao has a beta of -0.13, indicating that its stock price is 113% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and price targets for Strata Skin Sciences and Zhongchao, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1	0	0	0	1.00
Zhongchao	1	0	0	0	1.00

Summary

Strata Skin Sciences beats Zhongchao on 5 of the 9 factors compared between the two stocks.

About Strata Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

About Zhongchao

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.